欧盟 - 斯洛伐克文 - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastické činidlá - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

欧盟 - 斯洛伐克文 - EMA (European Medicines Agency)

h. lundbeck a/s - eptinezumab - poruchy migrény - analgetiká - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.

欧盟 - 斯洛伐克文 - EMA (European Medicines Agency)

pfizer europe ma eeig  - rimegepant - poruchy migrény - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.

欧盟 - 斯洛伐克文 - EMA (European Medicines Agency)

fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - všetky ostatné terapeutické produkty - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.

欧盟 - 斯洛伐克文 - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - atogepant - poruchy migrény - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.

欧盟 - 斯洛伐克文 - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - crisantaspase - prekurzorová bunková lymfoblastická leukémia-lymfóm - antineoplastické činidlá - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.

欧盟 - 斯洛伐克文 - EMA (European Medicines Agency)

merck sharp & dohme b.v. - elbasvir, grazoprevir - hepatitída c, chronická - direct acting antivirals, antivirals for systemic use, antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 a 5. pre vírusom hepatitídy c (hcv) genotyp-konkrétne aktivity pozri časť 4. 4 a 5.

斯洛伐克 - 斯洛伐克文 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stallergenes, francúzsko - rôzne extrakty alergénov - 59 - immunopraeparata

斯洛伐克 - 斯洛伐克文 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

boehringer ingelheim international gmbh, nemecko - tiotropiumbromid - 14 - bronchodilatantia, antiasthmatica